Skip to main content
. 2021 Aug 30;5(17):3266–3278. doi: 10.1182/bloodadvances.2021004355

Table 1.

Baseline characteristics of the Lifelines cohort and prevalence of cytopenias according to different proposed cutoff criteria.

n Total cohort <60 y old ≥60 y old
No. of individuals 152180 152180 129728 22452
Males 152180 63130 (41.5) 52886 (40.8) 10244 (45.6)
Age, median (range), y 152180 44 (18-93) 42 (18-59) 65 (60-93)
Hemoglobin level, mean (SD), g/dL 147170 14.14 (1.27) 14.12 (1.29) 14.24 (1.16)
Platelet count, mean (SD), ×109/L 147074 249.9 (56.6) 251.7 (56.4) 239.7 (56.8)
White blood cell count, mean (SD), ×109/L 147171 6.10 (1.79) 6.13 (1.73) 5.92 (2.11)
Neutrophil count, mean (SD), ×109/L 144676 3.33 (1.23) 3.36 (1.25) 3.15 (1.10)
Anemia (<12.0 g/dL [women] or <13.0 g/dL [men])* 147170 6159 (4.2) 5403 (4.2) 756 (3.4)
 Moderate (<11.0 g/dL) 147170 1272 (0.9) 1186 (0.9) 86 (0.4)
 Severe (<10.0 g/dL),§ 147170 442 (0.3) 419 (0.3) 23 (0.1)
Thrombocytopenia (<150 × 109/L)* 147074 2408 (1.6) 1777 (1.4) 631 (2.8)
  Moderate (<100 × 109/L),§ 147074 153 (0.1) 117 (0.09) 36 (0.2)
Neutropenia (<1.8 × 109/L)*, 144676 6925 (4.8) 5643 (4.3) 1282 (5.7)
 Moderate (<1.5 × 109/L) 144676 2050 (1.4) 1644 (1.3) 406 (1.8)
 Severe (<0.8 × 109/L)§ 144676 30 (0.02) 27 (0.02) 3 (0.01)

Unless otherwise noted, data are n (%).

SD, standard deviation.

*

Generally accepted reference values, argued for by Greenberg et al to define cytopenias in MDSs11 and used to define ICUS in 2017.10

Used to define ICUS in 2007.13

WHO criteria to define cytopenias in MDS.14

§

Alternative criteria to define cytopenias relevant for prognosis in MDS (IPSS-R).12